Brister Mark 4
4 · OBALON THERAPEUTICS INC · Filed Aug 8, 2019
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Purchase
Warrants (Right to Buy)
2019-08-06+3,750→ 3,750 totalExercise: $4.40From: 2019-08-06Exp: 2024-08-06→ Common Stock (3,750 underlying) - Purchase
Common Stock
2019-08-06$4.00/sh+5,000$20,000→ 38,865 total
Footnotes (2)
- [F1]Reflects price paid to underwriters in Issuer's registered offering.
- [F2]Includes Restricted Shares that are subject to vesting.